+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rabeprazole"

From
Gastroesophageal Reflux Disease (GERD) Market Report 2025 - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Antacids Market Report 2025 - Product Thumbnail Image

Antacids Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Proton Pump Inhibitors Market Report 2025 - Product Thumbnail Image

Proton Pump Inhibitors Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Rabeprazole is a proton pump inhibitor (PPI) used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. It is also used to reduce the risk of gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Rabeprazole works by blocking the production of acid in the stomach, which helps to reduce symptoms of acid reflux and other gastrointestinal disorders. Rabeprazole is available in both generic and brand-name formulations. It is typically taken once daily, and is available in tablet, capsule, and oral suspension forms. Common side effects of rabeprazole include headache, nausea, diarrhea, and abdominal pain. Rabeprazole is one of the most commonly prescribed PPIs for the treatment of gastrointestinal disorders. It is widely available in pharmacies and is covered by most insurance plans. Some companies that produce rabeprazole include Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, and Teva Pharmaceuticals. Show Less Read more